Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Funding

Clinical  ·  Weekly Digest - 13 June to 19 June 2026
Akeso’s HER3 ADC AK138D1 in combination with Ivonescimab phase 1/2 Breast cancer trial enrolls first patient

Weekly Digest – June 2026 Weekly Digest – June 2026 15 June 2026: Akeso’s HER3 ADC AK138D1 in combination with Ivonescimab phase 1/2 Breast cancer trial enrolls first patient Akeso has announced the enrollment of the first patient in the […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 13 June to 19 June 2026
Lonza grants Antharis exclusive license to develop dual-payload ADCs for GI cancers

Weekly Digest – June 2026 Weekly Digest – June 2026 15 June 2026: Lonza grants Antharis exclusive license to develop dual-payload ADCs for GI cancers Antharis Therapeutics has entered into an exclusive, target-specific licensing agreement with Lonza to develop next-generation […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 06 June to 12 June 2026
China NMPA approves Zai Lab’s TIVDAK for recurrent or metastatic Cervical cancer

Weekly Digest – June 2026 Weekly Digest – June 2026 08 June 2026: China NMPA approves Zai Lab’s TIVDAK for recurrent or metastatic Cervical cancer Zai Lab has received approval from China’s National Medical Products Administration for TIVDAK for the […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 06 June to 12 June 2026
CDSCO approves Trastuzumab deruxtecan plus Pertuzumab for first-line HER2-positive metastatic Breast cancer

Weekly Digest – June 2026 Weekly Digest – June 2026 11 June 2026: CDSCO approves Trastuzumab deruxtecan plus Pertuzumab for first-line HER2-positive metastatic Breast cancer AstraZeneca Pharma India has received CDSCO approval for Enhertu in combination with pertuzumab as a […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 06 June to 12 June 2026
China NMPA grants IND clearance to ADRX-0405 for advanced Solid tumors and Prostate cancer

Weekly Digest – June 2026 Weekly Digest – June 2026 08 June 2026: China NMPA grants IND clearance to ADRX-0405 for advanced Solid tumors including Prostate cancer Adcentrx Therapeutics has received Investigational New Drug clearance from China’s National Medical Products […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 06 June to 12 June 2026
Merck and Gilead discontinue phase 3 KEYNOTE-D46/EVOKE-03 study of Trodelvy plus Keytruda in 1L metastatic NSCLC

Weekly Digest – June 2026 Weekly Digest – June 2026 08 June 2026: Merck and Gilead discontinue phase 3 KEYNOTE-D46/EVOKE-03 study of Trodelvy plus Keytruda in 1L metastatic NSCLC Merck and Gilead have announced the discontinuation of the phase 3 […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 06 June to 12 June 2026
AmMax Bio licenses antibody-drug conjugate technology for Hematological cancers from Lonza

Weekly Digest – June 2026 Weekly Digest – June 2026 09 June 2026: AmMax Bio licenses antibody-drug conjugate technology for Hematological cancers from Lonza AmMax Bio has entered into a licensing agreement with Lonza to access its clinically validated antibody-drug […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 06 June to 12 June 2026
Johnson & Johnson to acquire Firefly Bio to expand oncology pipeline with degrader ADC platform

Weekly Digest – June 2026 Weekly Digest – June 2026 08 June 2026: Johnson & Johnson to acquire Firefly Bio to expand oncology pipeline with degrader ADC platform Johnson & Johnson has entered into a definitive agreement to acquire Firefly […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 30 May to 05 June 2026
Innovent Biologics’ IBI343 met primary endpoint in phase 3 Gastric cancer trial with NDA accepted by NMPA

Weekly Digest – June 2026 Weekly Digest – June 2026 04 June 2026: Innovent Biologics’ IBI343 met primary endpoint in phase 3 Gastric cancer trial with NDA accepted by NMPA Innovent Biologics has announced that IBI343, a CLDN18.2-targeted antibody-drug conjugate, […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 30 May to 05 June 2026
SOTIO receives U.S. FDA Orphan Drug Designation for SOT106, a potential best-in-class ADC for Sarcoma

Weekly Digest – June 2026 Weekly Digest – June 2026 03 June 2026: SOTIO receives U.S. FDA Orphan Drug Designation for SOT106, a potential best-in-class ADC for Sarcoma SOTIO announced that the U.S. FDA has granted Orphan Drug Designation to […]

by Sandhya Ramalingam

Continue Reading
« First‹ Previous34567891011Next ›Last »
Page 7 of 55


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id